Gene-Environment-Interaction: Influence of the COMT Genotype on the Effects of Different Cannabinoids - a PET Study

NCT02492074 · clinicaltrials.gov ↗

PHASE1

Phase

WITHDRAWN

Status

OTHER

Sponsor class

Stopped No documents were ever submitted to the Ethics Committee or the competent authority because it was not possible to establish the planned PET measurements in Germany. Therefore, the study never started.

Conditions

Healthy Volunteers
Modeling Psychosis

Interventions

DRUG: Delta-9-tetrahydrocannabinol
DRUG: Cannabidiol
DRUG: Placebo

Sponsor

Central Institute of Mental Health, Mannheim